EUVIMEDEUVIMED entdecken
Crossref

Rates of Screening, Diagnosis, and Treatment of Depression in Patients With Extremity Soft Tissue Sarcomas

Eduardo Williams-Medina iD, Brian Benyamini iD, Zachary D Burke iD, Nathan Mesko, Dale Shepard, Joseph Wooley, Jacob Scott iD, Lukas Nystrom iD

Musculoskeletal Care · 2026-12 · 24 (4)

DOI: 10.1002/msc.70289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Musculoskeletal Care, online erschienen am 15.11.2026. Verfasst von Eduardo Williams-Medina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Sarcoma, Depression, Extremities. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Soft tissue sarcomas (STS) are rare malignancies that can be associated with physical and psychological burden. Depression is a common comorbidity in cancer patients; however, mental health screening and treatment patterns in STS remain poorly characterised. This study evaluated national rates of depression screening, diagnosis, and antidepressant use among patients with extremity STS.

Methods

Using the TriNetX U.S. Collaborative Network, we conducted a retrospective matched cohort study of adults diagnosed with extremity STS between 2007 and 2025. Patients with no cancer history served as controls. Primary outcomes included encounters for depression screening, brief emotional/behavioural assessment, depression‐associated diagnoses, and antidepressant prescriptions. Subgroup analyses compared STS patients receiving chemotherapy and/or radiation therapy versus those who did not.

Results

After matching, 7295 patients were included per cohort. Compared with controls, patients with extremity STS had significantly lower risks of encounters for depression screening (RR: 0.13, 95% CI: 0.10–0.17) and brief emotional/behavioural assessment (RR: 0.17, 95% CI: 0.13–0.23). In contrast, patients with extremity STS had an increased risk of depression associated diagnoses (RR: 1.99, 95% CI: 1.76–2.24) and antidepressant prescriptions (RR: 1.81, 95% CI: 1.65–1.98). Among STS patients, those receiving chemotherapy and/or radiation therapy had higher risks of depression‐associated diagnoses (RR 1.30, 95% CI 1.10–1.54) and antidepressant use (RR 1.83, 95% CI 1.61–2.09).

Conclusion

Patients with extremity STS were less likely to undergo depression screening, suggesting under‐recognition of depression despite elevated psychosocial risk. Those receiving chemotherapy and/or radiation therapy demonstrated higher depression‐related diagnoses and antidepressant use. Integrating mental health screening and support throughout sarcoma care may enhance comprehensive patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaDepressionExtremitiesHumansFemaleMaleRetrospective StudiesMiddle AgedAntidepressive AgentsAgedAdultMass ScreeningUnited States

Stichwörter der Autor:innen

depressiononcologic carepsychiatric caresarcoma

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Eduardo Williams-Medina, Brian Benyamini, Zachary D Burke, Jacob Scott, Lukas Nystrom

Zitieren

APA

Williams-Medina, E., Benyamini, B., Burke, Z. D., Mesko, N., Shepard, D., Wooley, J., Scott, J., & Nystrom, L. (2026). Rates of Screening, Diagnosis, and Treatment of Depression in Patients With Extremity Soft Tissue Sarcomas. Musculoskeletal Care, 24(4). https://doi.org/10.1002/msc.70289

Vancouver

Williams-Medina E, Benyamini B, Burke ZD, Mesko N, Shepard D, Wooley J, et al. Rates of Screening, Diagnosis, and Treatment of Depression in Patients With Extremity Soft Tissue Sarcomas. Musculoskeletal Care. 2026;24(4). doi:10.1002/msc.70289

BibTeX
@article{WilliamsMedina2026,
  author = {Williams-Medina, Eduardo and Benyamini, Brian and Burke, Zachary D and Mesko, Nathan and Shepard, Dale and Wooley, Joseph and Scott, Jacob and Nystrom, Lukas},
  title = {Rates of Screening, Diagnosis, and Treatment of Depression in Patients With Extremity Soft Tissue Sarcomas},
  journal = {Musculoskeletal Care},
  year = {2026},
  volume = {24},
  number = {4},
  doi = {10.1002/msc.70289}
}
Kostenlos starten →